Introduction: There is great interest in the nutritional strategies for the prevention of age-related cognitive decline, yet the best methods for nutritional assessment in the populations at risk for dementia are still evolving. Our study objective was to examine the reliability and validity of the 2 common nutritional assessments (plasma nutrient biomarkers and Food Frequency Questionnaire) in the people at risk for dementia.
T he age-strata growing most rapidly in the United States include those reaching their 85th and 65th birthdays beginning this year. This wave of aging elders has implications for sporadic Alzheimer disease (AD) because age itself is a major risk factor. 1 Prevention and delay of onset in this most common form of dementia is therefore an important public health initiative.
An Alzheimer prevention strategy is becoming more feasible as we better understand populations at high risk, including older adults and those with amnestic-mild cognitive impairment (MCI). People at high risk for dementia experience more rapid rates of cognitive change over time, but care must be taken not to select persons with cognitive dysfunction that is too advanced. Several nutritional factors have been implicated in decline cognitive behavior and AD, although specific nutrition to prevent AD has remained illusive. [2] [3] [4] [5] [6] [7] [8] Nutrition that may modify the pathogenesis of AD include dietary antioxidants, [9] [10] [11] B vitamins, [12] [13] [14] [15] saturated and polyunsaturated fatty acids, [16] [17] [18] [19] and cholesterol. 20, 21 Vitamin D and some minerals may be important as well. [22] [23] [24] [25] It remains unclear whether modifying these nutritional factors can reduce the incidence of age-related cognitive decline, in part because reliable nutritional assessments in the people at risk are still evolving. Food frequency questionnaires (FFQ) are the best subjective method for assessing nutritional status in this setting because they reflect long-term dietary intake; the type of dietary exposure thought to be most important to neurodegeneration. The FFQ also challenge more generic memory as opposed to the episodic memory by asking usual frequency of foods consumed rather than querying specific meal recall that is a more difficult cognitive task. 26 However, FFQ does challenge recall memory and does not account for the genetic and nongenetic factors that may modify nutrition available to the brain independently of intake. [27] [28] [29] Combining nutritional biomarkers with FFQ is attractive because the inherent threats to validity of each measure are mostly independent. 30 Biochemical indicators of the dietary intake (ie, nutrient biomarkers) better represent nutrition with more direct access to the CNS. Some nutrient biomarkers may be less reflective of long-term dietary intake. The reliability for many nutrients biomarkers has not been evaluated in elders, and we are unaware of any study comparing FFQ and plasma nutrient estimates vis-a-vis in 2 groups distinctly different by memory state.
Reliability and validity studies of nutrient biomarkers in elder populations are limited, although more available in people under the age of 65 years. [31] [32] [33] [34] [35] The FFQ validity studies using the nutrient biomarkers in older persons are also limited. [36] [37] [38] [39] [40] [41] One report in the literature has collected dietary intake and careful classification of the cognitive status, but the assessment of cognition and diet were at different time points and no nutrient biomarker data was not reported. 42 Establishing reliable methods of the nutritional assessment in people at risk for dementia are imperative for the development of neuroprotective nutritional therapies. In this pilot study, we examined the reliability and validity of the FFQ and nutrient biomarkers in subjects with and without mild cognitive impairment. We hypothesized that nutrient biomarkers would outperform FFQ in this population well suited for the primary prevention of the Alzheimer disease.
METHODS

Participant Population
Nineteen participants with amnestic-MCI and 19 Nonimpaired elderly (NIE) were evaluated in the Aging and Alzheimer's clinic at Oregon Health and Science University after consent was obtained in accord with the Institutional Review Board for human study at OHSU.
The investigators identified MCI participants through routine clinical contact. The NIE were recruited as part of their ongoing participation in the longitudinal aging studies not collecting dietary information at the Layton Center for Aging and Alzheimer Research at OHSU. All the MCI and NIE participants then attended an in-clinic screening (with collateral historian for MCI) within 2 weeks of signing the consent and brought all medications (including supplements) that they were currently taking. All enrolled participants completed the study.
A consensus diagnosis was made at a diagnostic conference of neurologists and neuropsychologists held weekly at the Layton Center. Nonimpaired elders had no evidence of cognitive or functional impairment including Mini Mental State Exam Z28 and Clinical Dementia Rating=0. Amnestic-MCI was defined by Petersen criteria. 43 The assessment included interview with collateral historian, Mini Mental State Examination, 44 Cognistat, 45 Clinical Dementia Rating, 46 Wechsler Memory Scale-Revised (logical memory I and II), 47 the Geriatric Depression Scale, 48 Hachinski Ischemia Score, 49 Clock draw, and verbal fluency (recalling as many animals or words beginning with a specified letter in 60 s), physical and neurologic examination, and review of MRI.
Data Collection Methods
Blood Sampling Overview
Four 10-mL venous blood valutainers were obtained from each participant after an overnight fast. Serum tubes were allowed to clot at room temperature for 30 minutes before the centrifugation and separation of the serum. EDTA anticoagulated vials were wrapped in foil, placed immediately on ice, and centrifuged within 1 hour for plasma collection. Aliquots of 0.6 mL were collected and stored in Nunc 1.00-mL shaded cryotubes, labeled appropriately and immediately frozen for storage at À801C. Samples were defrosted and immediately assayed after standard procedures for these plasma nutrient biomarkers: (1) Vitamins: (ascorbic acid, a-and g-tocopherol, carotenoids, B vitamins, vitamin D) (2) Minerals: (copper, iron, magnesium, selenium, zinc) (3) Lipids: (linoleic acid, arachidonic acid, a-linolenic acid, eicosapentaenoic acid (EPA), Docosahexaenoic acid (DHA), total polyunsaturated fat, monounsaturated fat, saturated fat, and cholesterol).
Blood collection and analysis: Genetic determination of APOE allelic status was carried out with the use of polymerase-chain-reaction assay. 50 Plasma ascorbic acid was deproteinized with 10% metaphosphoric acid and the supernatant kept at À 801C until analysis with HPLC. 51 Plasma atocopherol was protected from light and heat, and stored at À801C until analyzed by HPLC with electrochemical detection after saponification in the presence of ascorbic acid and then extraction with hexane. 52 Plasma carotenoids were measured as described earlier. 53 In brief, plasma and lipoprotein fraction samples were protected from light and stored at À801C until analyzed. Echinenone in ethanol was added as an internal standard to 200-mL serum or lipoprotein fraction sample and 0.5 mL of 0.9% saline. The mixture was extracted by using 2-mL chloroform: methanol (2:1, by volume), mixed by vortex, centrifuged, and the chloroform layer was removed. A second extraction was done on the mixture with the use of 3-mL hexane, which was followed by mixing by vortex and centrifugation. The hexane layer was combined with the first extraction and evaporated to dryness under nitrogen. The residue from serum was redissolved in 150-mL ethanol, mixed by vortex, and sonicated for 30 seconds. A 50-mL aliquot was used for the HPLC analysis. A C 30 carotenoid column was used for the carotenoid measurements. Carotenoids were quantified by determining peak areas in the HPLC chromatograms and calibrated against known standards provided by DSM Nutritional Products, Parsippany, NJ. The percentage of carotenoids in each lipoprotein fraction was calculated as the absolute concentration of each fraction divided by the sum of the concentrations of all fractions. Plasma vitamin B6 (pyrodoxal 5-phosphate), folate, and vitamin B12 were measured by radioimmunoassay (ALPCO, Salem, NH). Plasma fatty acids were measured by gas spectrometry with chromatography as earlier described. 54 Plasma total cholesterol was separated from the serum by centrifugation and analyzed in the Lipid-Atherosclerosis Research Laboratory at OHSU in compliance with the standards set by the surveillance programs of the CDC in Atlanta, GA. 55 Plasma mineral content was determined by Inductively Coupled Plasma-Optical Emission Spectrometry (ICP-OES; Teledyne Leeman Labs, Hudson, New Hampshire) as described earlier with minor modifications. 56 In brief, 100 mL of plasma were digested in 1 mL 69% to 70% OmniTrace nitric acid (VWR, West Chester, VA) overnight. After digestion, the samples were diluted 10 times with chelex 100 resin (BIO-RAD, Hercules, CA) treated water and analyzed by ICP-OES against known standards.
Specimen quality control: Collection and storage of the MCI and NIE specimens was identical. Biologic specimens were collected from the fasting participants between the hours of 0700 and 1100 beginning in August 2006 with the final collection occurring in July 2007. Laboratory staff was blinded to the clinical diagnosis and dietary intake for all the study participants. Coefficient of variation was <6% for antioxidants (ascorbic acid, tocopherols, carotenoids) and fatty acids, <8% for B vitamins, and <6% for cholesterol.
Diet and Exercise Measures
The National Cancer Institute-Diet History Questionnaire was the FFQ used as a validated measure of the usual frequency of dietary intake consumption over the preceding year. 57 This FFQ probes for the frequency and portion of 124 food items consumed and also has dietary supplement questions. This measure takes about 1 to 2 hours to complete and was designed to facilitate easy completion. FFQ was used as opposed to 24-hour recall and food diary because it is less of a challenge to the episodic memory, widely used, and more reflective of longterm dietary intake. The FFQ was self-administered during the baseline and 1 month visits with trained personnel, introducing the questionnaire and being available to answer questions as needed, related to wording of the questions, portion sizes, and to assess completeness of data collection before participant dismissal. The same collateral historian accompanied MCI participants at each visit and was available for assisting the participant with the questionnaire. All the study participants successfully completed the FFQ. Raw data generated from the scanned FFQ were processed using Diet*Calc version 1.4.3 software developed by the National Cancer Institute (http://riskfactor.cancer. gov/FFQ).
The Physical Activity Scale in the Elderly (PASE) has been validated for use in people aged 65 to 100 years. 58 Scores range from 0 to 400 with greater activity level corresponding to a higher PASE score. The PASE is selfadministered and takes about 5 to 15 minutes to complete.
Statistical Methods
To assess the within participant measure variability, we compared the continuous plasma and FFQ nutrient estimates collected at baseline and 1 month. Means and standard deviations for plasma and FFQ estimates at baseline and 1 month were calculated (data not shown). T test of independent samples was used to determine differences between continuous variables age, BMI, physical activity, and by w 2 test for categoric variables (ie, gender, APOE genotype).
Intraclass correlation coefficients (ICC) were generated to assess the reliability of the plasma and FFQ estimates by these equation: ½r I ¼ s 2 a =ðs 2 a þ s 2 Þ. The r I is the ratio of between person variance (s 2 a ) divided by the sum of the between person and the within person variance (s 2 a + s 2 ). It ranges from 0 to 1, with r I =0 indicating no reliability (ie, large within person variability and 0 betweenperson variability) and r I =1 indicating perfect reliability (ie, 0 within person variability and large between person variability). The classification of reliability was defined a priori into ordinal categories and described in the subsequent results section. Many nutrient variables were not normally distributed and natural log (log e ) transformation was overall the most successful remedy per Shapiro-Wilk test. Residual method was used to adjust FFQ nutrient estimates for energy intake and plasma tocopherols for total plasma cholesterol. 59, 60 Pearson correlation coefficients tested the relationship between baseline plasma and FFQ nutrient estimates. Three models were created: (1) without adjustment as "Crude," (2) the adjustment for total energy intake as "Calorie-adjusted," and (3) age, gender, energy intake, ApoE genotype, and cholesterol as "Multivariate-adjusted." Supplementation was excluded from all analyses. The variables in the multivariate model were chosen based on earlier reported interaction with association between diet and plasma nutrients and differences observed in these variables among our 2 study groups. All analyses were calculated using SPSS 18 for Macintosh (Chicago, Ill) and 2-tailed a level was set at 0.05. (Table 1) The average age of the study population was 74 years, half were women (n=19) and half with amnestic-MCI, n=19. Thirty-four percent of the population carried the apolipoprotein e4 (eplison) allele (42% in MCI and 26% in NIE). The 2 groups were similar in age, BMI, cerebrovascular risk, activity level, kidney function, total energy intake, multivitamin supplementation, and freedom from depression. As expected, lower MMSE and higher acetylcholinesterase inhibitor use was observed in the MCI group. This group also had more men, statin users, and borderline lower plasma cholesterol ( Table 1 ).
RESULTS
Baseline Characteristics
Reliability of Nutrient Biomarkers and FFQ
Estimates for Vitamins, Minerals, and Lipids in the Total Population ( Fig. 1) Reliability was classified (a priori) into 4 catagories (1) "Poor" (ICC <0.40), (2) "Good" (0.40 <ICC <0.75), and (3) "Very Good" (ICC Z0.75). 61 A fourth category of "Excellent" was defined as ICC Z to plasma cholesterol observed in the study population (ICCZ0.92) as a clinically relevant benchmark of reliability. Twelve nutrient biomarkers rated "excellent" whereas no FFQ estimate reached this level of reliability. However, the overall range of reliability for all nutrient estimates was greater for plasma than the FFQ. Both the plasma and FFQ vitamins showed at least very good reliability with the exception of plasma C that rated good (Figs. 1A, B ). Vitamin D, b-cryptoxanthin, vitamin B12, lutein + zeaxanthin, a-tocopherol, a-carotene, lycopene, folate, and vitamin B6 showed to be more reliable in plasma than FFQ. Plasma and FFQ b-carotene and g-tocopherol had equal reliability considered "very good" by our criteria. FFQ vitamin C estimate outperformed plasma C. Plasma vitamin ICC ranged from 0.98 (vitamin D) to 0.49 (vitamin C) and 8/12 rated excellent. The range of ICC for FFQ vitamin estimates was less than plasma (0.90, vitamin C-0.77, folate), although no FFQ vitamin estimate rated "excellent".
The range for plasma mineral reliability was large (0.92, copper-0.23, iron) and FFQ range was smaller (0.86, selenium-0.70, magnesium). Copper and magnesium were more reliable in plasma, and zinc, selenium, and iron from FFQ (Figs. 1C, D) .
Plasma and FFQ lipid reliability was very good with the exception of plasma a-linolenic acid (Good). DHA, EPA, and total polyunsaturated fat (PUFA) had excellent reliability in plasma ( Fig. 1E ). Plasma linoleic acid, total saturated fat (SFA), arachidonic acid, and total monounsaturated fat (MUFA) had very good reliability. All FFQ lipid reliability was very good (Fig. 1F ). Plasma cholesterol, DHA, EPA, total PUFA, and linoleic acid were more reliable in plasma, and total SFA, arachidonic acid, total MUFA, and a-linolenic acid carried out better in FFQ.
The most reliable plasma nutrients in all elders were vitamin D (ICC=0.98), b-cryptoxanthin and vitamin B12 (both ICC=0.97), lutein + zeaxanthin (ICC=0.96), atocopherol (ICC=0.95), a-carotene (ICC=0.94), lycopene, folate, DHA, EPA, cholesterol, total PUFA, copper (all ICC=0.92), b-carotene (ICC=0.88), linoleic acid (ICC= 0.87), g-tocopherol (ICC=0.84), total SFA (ICC=0.82), vitamin B6 (ICC=0.80), arachidonic acid, and total MUFA (ICC=0.79).
The most reliable FFQ nutrient estimates in all elders were vitamin C (ICC=0.90), lutein + zeaxanthin, bcryptoxanthin, b-carotene, total SFA, and arachidonic acid (all ICC=0.88), cholesterol and vitamin D (both ICC=0.86), lycopene, and selenium (both ICC=0.86). (Fig. 2) We observed greater intraindividual variability (lower reliability) in FFQ estimates derived from nonimpaired elders (NIE) than in MCI. Ninety-six percent (25/26) of the FFQ estimates had very good or better reliability in MCI compared with 46% (12/26) in nonimpaired elders ( Figs.  2A, B ). Ten of these FFQ estimates in MCI rated excellent, whereas no ICC in NIE reached this level of reliability. The 10 most reliable FFQ estimates in NIE were a-carotene and b-cryptoxanthin (both ICC=0.89), b-carotene (ICC=0.88), lutein +zeaxanthin and lycopene (both ICC=0.86), vitamins D and C (both ICC=0.85), DHA (ICC=0.83), vitamin B12 (ICC=0.79), and EPA (ICC=0.78) ( Fig. 2A) . The most reliable FFQ estimates in MCI with the least intraindividual variability (greatest reliability) in MCI were PUFA, MUFA, linoleic acid, arachidonic acid, and cholesterol (all ICC=0.95), a-tocopherol, g-tocopherol, selenium, and vitamin C (all ICC=0.94), total saturated fat (ICC=0.93), and copper (ICC=0.92) (Fig. 2B) .
Reliability of Nutrient Biomarkers and FFQ Estimates by Cognitive Status
The plasma nutrient biomarkers were more reliable overall in the NIE compared with MCI (Figs. 2C, D) . The 10 most reliable nutrient biomarkers in NIE were b-cryptoxanthin (ICC=0.99), vitamin D (ICC=0.98), lutein + zeaxanthin, DHA, vitamin B12, a-tocopherol, and cholesterol (all ICC=0.97), EPA, copper, and lycopene (all ICC=0.94) (Fig. 2C) . The 10 most reliable nutrient biomarkers in the MCI were vitamin D (ICC=0.98), b-carotene (ICC=0.97), b-cryptoxanthin (ICC=0.95), lutein + zeaxanthin, vitamins B12 and B6 (all ICC=0.94), folate and PUFA (both ICC=0.92), linoleic acid (ICC=0.91), and a-tocopherol (ICC=0.90) (Fig. 2D ).
Correlation Between FFQ Nutrient Estimates and Respective Nutrient Biomarker (Table 2)
Twenty-six nutrients from both the plasma and the FFQ were classified into 3 categories (1) Vitamins (Ascorbic acid, a and g tocopherol, carotenoids, vitamin B6, folate and B12, and vitamin D), (2) Minerals (Copper, Iron, Magnesium, Selenium, Zinc), and (3) Lipids (total PUFA, MUFA, Saturated fat, Linoleic acid, Arachidonic acid, a-linolenic acid, EPA, DHA, Cholesterol).
FFQ carotenoids and long chain fatty acids correlate with plasma levels, but not in MCI. In MCI and NIE combined, FFQ estimates of lutein + zeaxanthin, b-cryptoxanthin, a-carotene, b-carotene, DHA, and EPA did positively correlate with their respective plasma biomarker ( Table 2 , Total). Correlation coefficients generated between FFQ and plasma levels of vitamin C, a-tocopherol, lycopene, folate, vitamin B12, vitamin D, copper, iron, zinc, total PUFA, linoleic acid, arachidonic acid, and a-linolenic acid all had a positive correlation coefficient but did not reach statistical significance.
In MCI, 12 of the 26 correlation coefficients generated between FFQ and plasma were positive (Table 2, MCI). By comparison, 17 of the 26 nutrients had positive coefficients in NIE, and 7 of these 17 did reach significance ( Table 2 , NIE). The calorie-and-multivariate adjusted models had no apparent advantage over the crude model unadjusted for energy intake and other variables ( 
DISCUSSION
This pilot study provides the short-term reliability of two commonly utilized nutritional assessments in a population at risk for Alzheimer's disease. The results may be considered preliminary for FFQ because of the limited sample size. However, these findings suggest that the reliability of vitamins, minerals, and lipids vary by the assessment method used and the nutrient understudy, but also, vary by memory state of the participant. Memory deficit reduced FFQ validity and appeared to inflate reliability compared to elders with intact memory.
Nutrient biomarker reliability in our study was consistent with other reports for vitamins and lipids. 34 Twelve of the nutrient biomarkers were at least as reliable as the commonly measured cholesterol and many may be relevant to neurodegeneration. These include lipophilic antioxidants, fatty acids, 1-carbon metabolism participants, vitamin D, and copper. FFQ nutrient estimate reliability was higher in amnestic MCI compared with nonimpaired elders (NIE). This can be interpreted as more stable or less variability in dietary intake in MCI compared with NIE. To test this hypothesis, we compared the reliability of the plasma nutrient biomarkers in the 2 groups. Interestingly, nutrient biomarker reliability in the MCI was lower compared with the NIE failing to support a more stable diet in MCI. More homogenous reporting of the dietary intake in MCI is a phenomenon that may be directly related to the nature of the memory deficit seen in this population who are essentially reporting "default" eating habits.
We observed more variability in nutrient biomarkers from MCI compared with NIE. This may be representing more true variability in the dietary intake in MCI, which is missed by the reporting bias associated with the FFQ. This could be explained by the differences in nutrient absorption and metabolism in MCI compared with NIE. We did observe a correlation between plasma vitamin B12 and folate with plasma homocysteine (r= À0.42, P=0.01 for both vitamin B12 and folate) and no correlation between FFQ B vitamin estimates and plasma homocysteine in this population. However, FFQ B vitamins did not relate to plasma homocysteine in either group suggesting that absorption and metabolism are no different between these 2 groups for B12 and folate.
Validating FFQ with plasma nutrient biomarkers is advantageous because these 2 measures have mostly independent measurement error. A correlation between FFQ and plasma nutrient therefore, provides strong documentation of qualitative FFQ validity. 30 FFQ and plasma correlations were strongest for carotenoids and long chain fatty acids. All together, 19 of the 26 correlation coefficients were at least in the appropriate direction (Table 2 Crude, Total). However, after stratifying by cognitive diagnosis, the MCI generated many more negative coefficients and the FFQ-plasma correlations in NIE were strengthened. This supports the view that short-term memory deficit attenuates any association between FFQ and plasma nutrient estimates. Besides memory state, other factors could explain weak correlation between the FFQ and plasma estimates including: differences in metabolism (ie, a-linolenic acid conversion 18:4 n-3 or EPA), genetic factors (ie, 5,10methylene-tetrahydrofolate reductase 677C-T polymorphism and B vitamins), and hypo/hyper responder in plasma nutrients by dietary intake (ie, diet and plasma cholesterol). Gender may also modify the relationship between the FFQ and plasma nutrients. Although we partially controlled gender in our analysis, our sample size restricted us from exploring effect modification by gender. Nevertheless, these data suggest that memory state of the participant has distinctly different effects on the reliability and validity of FFQ; reliability is falsely inflated, compared with controls and validity is decreased.
Some limitations of this pilot study include a relatively small sample size (n=38), homogenous ethnicity (all non-Hispanic, white), and no data beyond 1 month. The strengths include an elder population with expert classification of cognition, collection of FFQ twice over 1 month, which allows a period long enough for participants to forget their earlier responses and at the same time short enough to limit true change in diet, both factors affecting reliability. 30 Other strengths include the comprehensive panel of nutrient biomarkers studied and the collection of plasma, FFQ, and cognitive measures at the same time point for each study participant. These factors add unique strength to our inferences regarding reliability and validity of these nutritional assessments.
In conlusion, the reliability of exposure measures is particularly important in Alzheimer epidemiology because the neurodegenerative process is gradual, requiring large samples followed for an extensive period to assure adequate cognitive change. A highly reliable and valid instrument can minimize information bias and permit greater power for detecting true effects with less sample size. Many of the nutrient biomarkers tested highly reliable over 1-month. These biochemical indicators of dietary intake are less susceptible to sources of error associated with less direct and subjective methods of nutritional assessment. All together these results provide a strong basis for the longitudinal study of the relationship between nutrition and cognitive aging and Alzheimer disease, and the constitution of biospecimen banks at the baseline of observational and intervention studies for secondary analyses. 
